Basking Biosciences
Manufacturing · Ohio, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1275 Kinnear Rd, Columbus, Ohio, 43212, ...Phone Number
(919) 345-7933Website
www.baskingbiosciences.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Basking Biosciences
Founded in 2019, Basking Biosciences is a clinical-stage company founded to solve the biggest need in ischemic stroke therapy for a rapid-onset, short-acting thrombolytic drug capable of reopening blocked arteries within a significantly extended therapeutic window than currently approved therapies, and whose activity can be quickly reversed in the event of bleeding. The company is developing BB-031, a first-in-class RNA aptamer targeting von Willebrand Factor (vWF), an important structural component of blood clots and driver of the clotting process. The company is also developing BB-025 in tandem, a complementary rapid-acting reversal oligonucleotide capable of quickly neutralizing BB-031 pharmacological activity. Non-clinical research in multiple gold-standard animal models demonstrated that BB-031 quickly recanalized blocked blood vessels in the brain, as late as six hours after stroke onset. Basking has successfully completed a Phase 1 single-ascending dose safety study with BB-031Read more
Basking Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Basking Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Basking Biosciences is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Basking Biosciences has recently received funding, and reach out quickly before it becomes old news!
Basking Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Basking Biosciences had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Basking Biosciences
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Basking Biosciences recently announced quarterly report
Funding: Get notified immidiatlly once Basking Biosciences has new funding data
Product Launch: Get notified when Basking Biosciences launches new products
Recommended Actions
Reach out to Masked Content who joined Basking Biosciences as Masked Content
Find more new buyers
Compare Similar Companies to Basking Biosciences
Compare insights from companies similar to Basking Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Basking Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Basking Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Basking Biosciences.
Basking Biosciences financials insights
Gather financial insights about Basking Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Angel/Seed
$5.4M
2024
Other Financing Round
$55M
Basking Biosciences Tech Stack
A closer look at the technologies used by Basking Biosciences
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
New Hire
Executive Move
Executive Moves, New Hire
Basking Biosciences News & Media
Basking Biosciences Announces First Participants Dosed in Phase 1 Study of BB-025, a Direct-Acting Reversal Agent for Investigational Stroke Therapy BB-031
-First clinical evaluation of BB-025, designed to rapidly and specifically reverse BB-031 activity, advancing Basking's goal to redefine thrombosis treatment- RESEARCH TRIANGLE, N.C., Nov. 12, 2025 /PRNewswire/ -- Basking Biosciences (Basking), a clinical-stage biopharmaceutical company...Basking Biosciences Doses First Patients in Part B of Phase 2 Stroke Trial, Unlocks $27.5 Million Financing Tranche, and Appoints Julia C. Owens, Ph.D. as Chief Executive Officer
-Financing supports execution of Phase 2b RAISE trial evaluating BB-031, an investigational reversible thrombolytic for acute ischemic stroke, and the planned Phase 1 study of BB-025, its fast-acting reversal agent- -Current CEO Richard Shea transitions to President and Chief Operating...Latest Updates of Viva Biotech's Portfolio Companies
HONG KONG, Oct. 30, 2024 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the success of commercialization. Recently, Viva Biotech's portfolio companies have new updates. Keep reading for more details. Seraxis Announces FDA IND Allowance for Clinical Study of SR-02 Replacement IsletsBasking Biosciences Doses First Patients in Phase 2 Clinical Trial of Reversible Thrombolytic BB-031 for Acute Ischemic Stroke
COLUMBUS, Ohio--(BUSINESS WIRE)--Basking Biosciences (Basking), a clinical-stage biopharmaceutical company developing a novel acute thrombolytic therapy, today announced that the first patients have been dosed in RAISE, a Phase 2 clinical trial evaluating BB-031 in patients presenting with acute ischemic stroke (AIS). “We are excited to announce the initiation of patient enrollment in the RAISE trial,” said Richard Shea, Chief Executive Officer of Basking. “This milestone brings us closer to de
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Basking Biosciences
Sign Up For FreeTo access detailed company insights
Founded in 2019, Basking Biosciences is a clinical-stage company founded to solve the biggest need in ischemic stroke therapy for a rapid-onset, short-acting thrombolytic drug capable of reopening blocked arteries within a significantly extended therapeutic window than currently approved therapies, and whose activity can be quickly reversed in the... Read More
